Съдържание:
  • Introduction
  • The U.S. blood supply system
  • History of the controversy
  • Product treatment
  • Donor screening and deferral
  • Regulations and recall
  • Risk communication to physicians and patients
  • Conclusions and recommendations
  • Appendixes
  • Tables and figures.